There are 2789 resources available
1759MO - Associations between sarcopenia and gut microbiota in patients (pts) with metastatic renal cell carcinoma (mRCC) and breast cancer (BC)
Presenter: Zeynep Zengin
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
LBA68 - Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1761MO - Defining subset-wise myeloid responses to immune checkpoint blockade in melanoma
Presenter: Rosalin Cooper
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
861MO - Spatial distribution of CD8+ and FoxP3+ in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (HNSCC)
Presenter: Joseph Curry
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
Discussion LBA52, LBA53, LBA54 and LBA55
Presenter: Yelena Janjigian
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Discussion 960MO, 961MO and 962MO
Presenter: Thomas Gajewski
Session: Mini oral session - Investigational immunotherapy
Resources:
Slides
Webcast
Discussion 1373MO, LBA10 and LBA37
Presenter: Changhoon Yoo
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
61MO - Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199
Presenter: Julie Graff
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Yes
Presenter: Jonas Bergh
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast